23521-81-5

Basic information

• Product Name: (1,4-dioxaspiro[4.5]dec-8-yl)methanol
• CAS NO: 23521-81-5
• Molecular Weight: 172.224
• Mol File: 23521-81-5.mol
• Article Data: 51

Chemical Properties

• CAS DataBase Reference: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(23521-81-5)
• EPA Substance Registry System: (1,4-dioxaspiro[4.5]dec-8-yl)methanol(23521-81-5)

Safety Data

• Hazardous Substances Data: 23521-81-5(Hazardous Substances Data)

Upstream product

• 26845-47-6 methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 51656-90-7 8-methylene-1,4-dioxaspiro[4.5]decane 
• 38580-68-6 4-hydroxymethyl-cyclohexanone 
• 107-21-1 ethylene glycol 
• 1489-97-0 ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 6297-22-9 4-carbomethoxycyclohexanone 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 3289-28-9 ethyl cyclohexanecarboxylate 
• 93245-98-8 1,4-dioxaspiro[4.5]decane-8-carbaldehyde 
• 3685-22-1 4-hydroxycyclohexanecarboxylic acid 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 183-97-1 1,4,9,12-Tetraoxa-dispiro[4.2.4.2]tetradecane 
• 59691-19-9 1-Methoxy-4-(hydroxymethyl)-1,4-cyclohexadiene 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 132452-42-7 8-((benzyloxy)methyl)-1,4-dioxaspiro[4.5]decane 
• 599174-28-4 C₃₂H₄₂N₄O₇S 
• 93245-98-8 1,4-dioxaspiro[4.5]decane-8-carbaldehyde 
• 17159-86-3 4-(ethoxymethyl)cyclohexanone 
• 1358762-61-4 8-benzyloxymethyl-1,3-diaza-spiro[4.5]decane-2,4-dione 
• 1358762-63-6 8-(p-toluenesulfonyloxymethyl)-1,3-diaza-spiro[4.5]decane-2,4-dione 
• 1187964-14-2 ethyl 3-{1,4-dioxaspiro[4.5]decan-8-yl}propanoate 
• 58012-66-1 3-(4-oxocyclohexyl)propionic acid ethyl ester 

Relevant articles and documents

A Photochemical Approach to the Taxanes

The de Mayo sequence has been applied to the inter- and intramolecular photocycloaddition of various cycloalkenes with homocamphorquinone derivatives to generate a model for the A, B, and C rings of the taxanes.A model sequence of reactions applicable to

3-(dimethylaminomethyl) cyclohex-4-alcohol derivative as well as preparation method and pharmaceutical application thereof

The invention belongs to the field of pharmacy, and relates to a 3-(dimethylaminomethyl) cyclohex-4-alcohol derivative with a general formula (I) or a salt thereof and a preparation method, and relates to an application of the compound in treatment of opioid receptor mediated diseases. The present invention provides a pharmaceutically acceptable solvate or hydrate of a compound of formula (I), and also provides a pharmaceutical composition comprising: a compound of formula (I) or a pharmaceutically acceptable salt, solvate or hydrate thereof; and a pharmaceutically acceptable carrier. The medicine prepared from the compound can be used for treating or improving diseases related to an opioid receptor; wherein the diseases can be selected from but not limited to pain, gastrointestinal diseases and depression.

LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT

PROBLEM TO BE SOLVED: To improve Δn of a liquid crystal compound. SOLUTION: One aspect of the present invention is a liquid crystal compound represented by general formula (i) [where Ri1 is a C1 to 15 alkyl group or the like, Ri2 is

Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors

The design, synthesis and structure-activity relationships associated with a series of bridged tricyclic pyrimidinone carboxamides as potent inhibitors of HIV-1 integrase strand transfer are described. Structural modifications to these molecules were made in order to examine the effect on potency towards wild-type and clinically-relevant resistant viruses. The [3.2.2]-bridged tricyclic system was identified as an advantageous chemotype, with representatives exhibiting excellent antiviral activity against both wild-type viruses and the G140S/Q148H resistant virus that arises in response to therapy with raltegravir and elvitegravir.